Cargando…

Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection

OBJECTIVES: Mucosal-associated invariant T (MAIT) cells have been shown to contribute in the pathogenesis of various liver diseases, including chronic hepatitis C virus (HCV) infection. This study was aimed at investigating the frequency, phenotype, and function of circulating MAIT cells, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khlaiphuengsin, Apichaya, Chuaypen, Natthaya, Sodsai, Pimpayao, Reantragoon, Rangsima, Han, Win Min, Avihingsanon, Anchalee, Tangkijvanich, Pisit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775079/ https://www.ncbi.nlm.nih.gov/pubmed/33382729 http://dx.doi.org/10.1371/journal.pone.0244112

Ejemplares similares

Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma
por: Khlaiphuengsin, Apichaya, et al.
Publicado: (2020)

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono-Infection and HCV/HIV Co-Infection
por: Kiatbumrung, Rattanaporn, et al.
Publicado: (2018)

Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection
por: Chuaypen, Natthaya, et al.
Publicado: (2023)

Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Pinjaroen, Nutcha, et al.
Publicado: (2023)

Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma
por: Boonkaew, Bootsakorn, et al.
Publicado: (2023)

An innovative wireless electrochemical card sensor for field-deployable diagnostics of Hepatitis B surface antigen
por: Teengam, Prinjaporn, et al.
Publicado: (2023)

Circulating microtranscriptome profiles reveal distinct expression of microRNAs in severe leptospirosis
por: Limothai, Umaporn, et al.
Publicado: (2020)

Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis
por: Chuaypen, Natthaya, et al.
Publicado: (2021)

Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus–related hepatocellular carcinoma
por: Pratedrat, Pornpitra, et al.
Publicado: (2020)

Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals
por: Chuaypen, Natthaya, et al.
Publicado: (2019)

Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Kunadirek, Pattapon, et al.
Publicado: (2022)

Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study
por: Jinato, Thananya, et al.
Publicado: (2022)

The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
por: Patarat, Rathasapa, et al.
Publicado: (2021)

Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand
por: Kunadirek, Pattapon, et al.
Publicado: (2021)

Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Kunadirek, Pattapon, et al.
Publicado: (2021)

Targeted Proteins Reveal Cathepsin D as a Novel Biomarker in Differentiating Hepatocellular Carcinoma from Cirrhosis and Other Liver Cancers
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand
por: Suwimol, Sapwarobol, et al.
Publicado: (2022)

Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor
por: Reantragoon, Rangsima, et al.
Publicado: (2012)

The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2
por: Oekchuae, Sittisak, et al.
Publicado: (2022)

Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery
por: Ruenjaiman, Vichaya, et al.
Publicado: (2022)

Increased interleukin-23 receptor(+ )T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Puwipirom, Hathaipat, et al.
Publicado: (2010)

Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application
por: Hayashi, Sanae, et al.
Publicado: (2022)

A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells
por: Eckle, Sidonia B.G., et al.
Publicado: (2014)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8
por: Tangtanatakul, Pattarin, et al.
Publicado: (2017)

Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds
por: Ruengsatra, Tanachote, et al.
Publicado: (2023)

MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury
por: Ariyachet, Chaiyaboot, et al.
Publicado: (2022)

Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
por: Reantragoon, Rangsima, et al.
Publicado: (2013)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Use of Hepatitis B-e Antigen to Identify Pregnant Women With Hepatitis B Virus Infection Who Need Antiviral Therapy for Prevention of Mother-to-child Transmission
por: Jiragraivutidej, Chanya, et al.
Publicado: (2021)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Mucosal‐associated invariant T‐cell frequency and function in blood and liver of HCV mono‐ and HCV/HIV co‐infected patients with advanced fibrosis
por: Beudeker, Boris J. B., et al.
Publicado: (2017)

Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals
por: Macek Jílková, Zuzana, et al.
Publicado: (2020)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2v0tiorckkjcpkeda28ktit4p